Back

EBCL-0022

Nuclear Hormone Receptor Ligands

Nuclear hormone receptors (NHRs) are representatives of a large class of proteins within cells. They act as receptors for a wide range of molecules, such as vitamin A-derivative retinoids, steroid and thyroid hormones, and others. Activated by binding of the signal molecule, the ligand–NHR complex changes its conformation and modifies the expression of certain genes by binding to control elements in the DNA. Thus, NHRs play a major role in embryonic development and adult homeostasis. Over 10% of FDA-approved drugs target NHRs as perspective objects in the control of various diseases.

Nuclear Hormone Receptor Ligands Library is composed of 758 small ligands. The collection includes ligands that display all major types of action on NHR targets: agonistic, antagonistic, and inverse agonistic.

 

Related terms: pregnane X receptor, peroxisome proliferator-activated receptor, estrogen, androgen, farnesoid X receptor, vitamin D

Library image

Mechanism of action for class I NHRs(Created by BioRender.com)

Preplated options

Dry powder/solution (DMSO)Dry powder
Number of compounds758
Comment
Dry powder/solution (DMSO)DMSO
Number of compounds552
Comment

Highlights

Molecule highlight
EBC-07864CAS: 65928-58-7

Dienogest, progesterone receptor agonist EBC-07864

Molecule highlight
EBC-17092CAS: 1297538-32-9

Darolutamide, androgen receptor antagonist EBC-17092

Molecule highlight
EBC-07875CAS: 1426802-50-7

GSK805, ROR-gamma receptor inverse antagonist EBC-07875

Get an individual offer

We propose the complete list of Services powered by Enamine

Select size
Select format
Disclaimer

All our products are for research purpose only. Any personal or non-scientific use is strictly prohibited.

Note

All the compounds with solubility below 10 mM are shipped as 2 mM solutions.

Product Features

  • A set of 758 NHR-binding molecules with sub-10 micromolar activity coefficient values for HTS/HCS programs.
  • The library is composed of ligands that target all major pharmaceutically relevant NHR targets.
  • Nuclear Hormone Receptor Ligands Library covers novel promising preclinical lead compounds, clinical candidates and approved drugs.
  • Calculated structural diversity of the collection: 0.87.
  • Comprehensive documentation with structures, trivial names, synonyms, activity coefficient values, types of action on target and references to original literature.
  • NMR and LCMS validated purity.
  • All the compounds are available in stock for hit follow-up.
  • The library is continuously updated.

Product Details

  • Format: 10 - 100 µL of 10 mM DMSO stock solutions; dry powders (1 mg);
  • Container: 384-well microplates;
  • Storage: - 18 °C;
  • Shipping: Dry ice.

Utility

  • High throughput screening (HTS);
  • High content screening (HCS);
  • Cherry picking.